X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5702) 5702
Publication (335) 335
Book Review (18) 18
Book Chapter (15) 15
Dissertation (3) 3
Conference Proceeding (2) 2
Book / eBook (1) 1
Government Document (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4301) 4301
female (2764) 2764
male (2628) 2628
oncology (2606) 2606
antineoplastic combined chemotherapy protocols - therapeutic use (2266) 2266
middle aged (2181) 2181
vinblastine - administration & dosage (2096) 2096
vinblastine (2045) 2045
adult (1946) 1946
aged (1910) 1910
chemotherapy (1889) 1889
index medicus (1802) 1802
vinblastine - analogs & derivatives (1585) 1585
cancer (1292) 1292
treatment outcome (1237) 1237
animals (1093) 1093
cisplatin - administration & dosage (1049) 1049
cisplatin (1000) 1000
vinblastine - pharmacology (995) 995
survival analysis (899) 899
antineoplastic combined chemotherapy protocols - adverse effects (843) 843
vinorelbine (821) 821
neoplasm staging (781) 781
vinblastine - therapeutic use (760) 760
lung neoplasms - drug therapy (757) 757
carcinoma, non-small-cell lung - drug therapy (681) 681
prognosis (673) 673
vinblastine - adverse effects (649) 649
adolescent (644) 644
doxorubicin - administration & dosage (637) 637
doxorubicin (630) 630
retrospective studies (617) 617
aged, 80 and over (598) 598
deoxycytidine - analogs & derivatives (590) 590
combined modality therapy (589) 589
antineoplastic combined chemotherapy protocols - administration & dosage (579) 579
survival rate (558) 558
bleomycin - administration & dosage (551) 551
disease-free survival (547) 547
hodgkin disease - drug therapy (535) 535
pharmacology & pharmacy (535) 535
methotrexate (532) 532
survival (516) 516
therapy (482) 482
deoxycytidine - administration & dosage (480) 480
care and treatment (469) 469
mice (452) 452
follow-up studies (438) 438
lung neoplasms - pathology (427) 427
drug administration schedule (423) 423
gemcitabine (417) 417
analysis (416) 416
trial (411) 411
breast neoplasms - drug therapy (406) 406
paclitaxel (402) 402
research (387) 387
medicine & public health (384) 384
hematology (381) 381
radiotherapy (375) 375
dose-response relationship, drug (371) 371
urinary bladder neoplasms - drug therapy (369) 369
carcinoma (364) 364
carcinoma, non-small-cell lung - pathology (363) 363
dacarbazine - administration & dosage (334) 334
antineoplastic agents - therapeutic use (326) 326
chemotherapy, adjuvant (323) 323
time factors (319) 319
tumors (315) 315
expression (306) 306
vincristine - administration & dosage (306) 306
bleomycin (301) 301
urology & nephrology (301) 301
paclitaxel - administration & dosage (300) 300
disease (299) 299
neoplasm metastasis (293) 293
cell line, tumor (290) 290
child (290) 290
hodgkin disease - pathology (287) 287
vincristine (284) 284
breast neoplasms - pathology (282) 282
hematology, oncology and palliative medicine (279) 279
p-glycoprotein (279) 279
cyclophosphamide - administration & dosage (278) 278
carboplatin (276) 276
breast cancer (273) 273
etoposide - administration & dosage (273) 273
prospective studies (273) 273
antineoplastic agents (272) 272
biochemistry & molecular biology (272) 272
combination (270) 270
combination chemotherapy (269) 269
metastasis (269) 269
cisplatin - therapeutic use (268) 268
prednisone - administration & dosage (268) 268
methotrexate - administration & dosage (265) 265
urinary bladder neoplasms - pathology (264) 264
remission induction (262) 262
rats (259) 259
antineoplastic agents - pharmacology (256) 256
bladder cancer (256) 256
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5529) 5529
Japanese (68) 68
French (52) 52
Chinese (35) 35
German (35) 35
Russian (16) 16
Spanish (15) 15
Italian (8) 8
Hungarian (4) 4
Polish (4) 4
Czech (3) 3
Hebrew (3) 3
Portuguese (2) 2
Bulgarian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Thoracic Oncology, ISSN 1556-0864, 06/2016, Volume 11, Issue 6, pp. 850 - 861
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
PLoS Medicine, ISSN 1549-1277, 12/2016, Volume 13, Issue 12, p. e1002136
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1328 - 1337
Adverse effects on reproductive function are a key concern in young women treated with chemotherapy for advanced Hodgkin's lymphoma. We aimed to identify risk... 
FIBROSIS | WOMEN | RESERVE | ONCOLOGY | ANTIMULLERIAN HORMONE | ANTI-MULLERIAN HORMONE | EARLY BREAST-CANCER | REPRODUCTIVE AGE | CHEMOTHERAPY | FERTILITY | AGONIST | Pets | Care and treatment | Chemotherapy | Anthracyclines | Analysis | Lymphomas | Product development | Cancer
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 425 - 434
Purpose Patients treated with chemoradiotherapy for locally advanced non–small-cell lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF)... 
Radiology | Hematology, Oncology and Palliative Medicine | Survival with respect to radiotherapy dose intensity | Local-regional failure | Radiation oncology | Chemoradiotherapy | Advanced non–small-cell lung carcinoma | Advanced non-small-cell lung carcinoma | LEUKEMIA GROUP-B | INDUCTION CHEMOTHERAPY | CONSOLIDATION DOCETAXEL | COMPETING RISK | FOLLOW-UP | CANCER | PHASE-III TRIAL | ONCOLOGY | HYPERFRACTIONATED RADIATION | CONCURRENT CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | THORACIC RADIOTHERAPY | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Treatment Failure | Aged, 80 and over | Adult | Female | Retrospective Studies | Paclitaxel - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Chemoradiotherapy - methods | Proportional Hazards Models | Carboplatin - administration & dosage | Etoposide - administration & dosage | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Amifostine - administration & dosage | Aged | Relative Biological Effectiveness | Medical colleges | Care and treatment | Carcinoma | Nuclear radiation | Patient outcomes | Lung cancer, Non-small cell | Radiotherapy | Cancer | Statistical analysis | Lung | Radiation | Clinical trials | Non-small cell lung carcinoma | Data processing | Dose-response effects | Oncology | Radiation therapy | Multivariate analysis | Survival | MULTIVARIATE ANALYSIS | PATIENTS | TESTING | FAILURES | LUNGS | CARCINOMAS | STANDARDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | RADIOTHERAPY | COMBINED THERAPY | HAZARDS | chemoradiotherapy | local-regional failure | Radiation Oncology | advanced non-small-cell lung carcinoma | survival with respect to radiotherapy dose intensity
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article